U.S. Biotechnology Stocks
606 companies by market cap.
There are 606 U.S.-listed companies in Biotechnology (Healthcare sector), with a combined market value of $1.32T. The largest is Vertex Pharmaceuticals Incorporated at 11% of the total. The median P/E is 14.8x, the median revenue growth is +8.5%, and 4 companies pay a dividend.
| # | Company | Market cap | P/E | Div. yield | Revenue YoY | 1Y return |
|---|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals IncorporatedVRTXVertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innova… | $139B | 31.6x | — | +10.6% | +31.4% |
| 2 | Moderna, Inc.MRNAModerna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapi… | $101B | — | — | −27.2% | +944.8% |
| 3 | Regeneron Pharmaceuticals, Inc.REGNRegeneron Pharmaceuticals, Inc. | $93.5B | 21.7x | 0.41% | +9.3% | +40.5% |
| 4 | argenx SEARGXargenx SE, a biotechnology company established in Amsterdam, the Netherlands, in 2008, is dedicated to developing innovative therapies prima… | $55.3B | 31.9x | — | — | +9.0% |
| 5 | BeOne Medicines AGONCBeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States,… | $43.5B | 27.0x | — | +34.3% | +22.4% |
| 6 | Revolution Medicines, Inc.RVMDRevolution Medicines, Inc. | $41.2B | — | — | — | +213.3% |
| 7 | Genmab A/SGMABGenmab A/S, a biopharmaceutical company founded in 1999 and headquartered in Copenhagen, Denmark, specializes in the discovery and developme… | $33B | 41.7x | — | −68.2% | +86.0% |
| 8 | Roivant Sciences Ltd.ROIVRoivant Sciences Ltd. | $28.1B | — | — | −67.6% | +89.0% |
| 9 | Insmed IncorporatedINSMInsmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing… | $25.1B | — | — | +185.8% | −38.4% |
| 10 | Incyte CorporationINCYIncyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. | $24.4B | 14.8x | — | +26.9% | +13.7% |
| 11 | United Therapeutics CorporationUTHRUnited Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for… | $24.1B | 18.6x | — | +2.5% | +23.8% |
| 12 | BioNTech SEBNTXBioNTech SE, a biotechnology firm, specializes in the creation and marketing of immune-based treatments for malignancies and various infecti… | $21.7B | — | — | −8.2% | −15.3% |
| 13 | Alnylam Pharmaceuticals, Inc.ALNYAlnylam Pharmaceuticals, Inc. | $20.9B | 25.6x | — | +95.1% | −64.6% |
| 14 | Exelixis, Inc.EXELExelixis, Inc. | $17.5B | 21.1x | — | +9.2% | +70.5% |
| 15 | Ascendis Pharma A/SASNDAscendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that curr… | $16.9B | 20.0x | — | +114.9% | +28.9% |
| 16 | Neurocrine Biosciences, Inc.NBIXNeurocrine Biosciences, Inc. | $16.7B | 23.2x | — | +34.4% | +6.4% |
| 17 | Jazz Pharmaceuticals plcJAZZJazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. | $15.1B | 15.3x | — | +12.6% | +75.1% |
| 18 | BridgeBio Pharma, Inc.BBIOBridgeBio Pharma, Inc. | $14.5B | — | — | +202.4% | +18.4% |
| 19 | Summit Therapeutics Inc.SMMTSummit Therapeutics Inc. | $13B | — | — | — | −11.5% |
| 20 | Halozyme Therapeutics, Inc.HALOHalozyme Therapeutics, Inc. | $11.8B | 29.4x | — | +41.2% | +51.5% |
| 21 | Bio-Techne CorporationTECHBio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services f… | $11.4B | 62.3x | 0.44% | −0.4% | +25.8% |
| 22 | Kymera Therapeutics, Inc.KYMRKymera Therapeutics, Inc. | $11.2B | — | — | +134.8% | +116.0% |
| 23 | BioMarin Pharmaceutical Inc.BMRNBioMarin Pharmaceutical Inc. | $10.8B | 147.4x | — | +11.2% | +8.1% |
| 24 | Vaxcyte, Inc.PCVXVaxcyte, Inc. | $10.1B | — | — | — | +53.2% |
| 25 | Spyre Therapeutics, Inc.SYRESpyre Therapeutics, Inc. | $9.6B | — | — | — | +363.9% |
| 26 | Madrigal Pharmaceuticals, Inc.MDGLMadrigal Pharmaceuticals, Inc. | $9.2B | — | — | +149.0% | −18.2% |
| 27 | TG Therapeutics, Inc.TGTXBased in New York City and established in 1993, TG Therapeutics, Inc. | $9.2B | 19.6x | — | +76.1% | +79.9% |
| 28 | ImmunityBio, Inc.IBRXImmunityBio, Inc. | $9.2B | — | — | +192.9% | +307.3% |
| 29 | Krystal Biotech, Inc.KRYSKrystal Biotech, Inc. | $8.9B | 36.5x | — | +22.6% | +50.5% |
| 30 | Protagonist Therapeutics, Inc.PTGXProtagonist Therapeutics, Inc. | $8.5B | 108.4x | — | +34.8% | +65.5% |
| 31 | Arrowhead Pharmaceuticals, Inc.ARWRArrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering… | $8.2B | — | — | +16.8% | +46.9% |
| 32 | Twist Bioscience CorporationTWSTTwist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed fro… | $8B | — | — | +19.2% | +294.4% |
| 33 | Praxis Precision Medicines, Inc.PRAXPraxis Precision Medicines, Inc. | $7.8B | — | — | — | +61.1% |
| 34 | Rhythm Pharmaceuticals, Inc.RYTMRhythm Pharmaceuticals, Inc. | $7.7B | — | — | +53.5% | +14.0% |
| 35 | Abivax S.A.ABVXAbivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic d… | $7.5B | — | — | — | −17.5% |
| 36 | Cytokinetics, IncorporatedCYTKCytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and… | $7.5B | — | — | −17.2% | −11.0% |
| 37 | Caris Life Sciences, Inc.CAICaris Life Sciences, Inc. | $7.1B | 67.8x | — | +85.4% | +2.5% |
| 38 | 10x Genomics, Inc.TXGHeadquartered in Pleasanton, California, 10x Genomics, Inc. | $7.1B | — | — | −4.3% | +356.0% |
| 39 | Axsome Therapeutics, Inc.AXSMAxsome Therapeutics, Inc. | $7B | — | — | +56.9% | −5.0% |
| 40 | Oruka Therapeutics, Inc.ORKAOruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psori… | $6.8B | — | — | — | +263.7% |
| 41 | CG Oncology Inc.CGONCG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients… | $6.7B | — | — | +1,030.3% | +91.5% |
| 42 | Ionis Pharmaceuticals, Inc.IONSFounded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. | $6.6B | — | — | −7.4% | −46.8% |
| 43 | Immunovant, Inc.IMVTImmunovant, Inc. | $6.3B | — | — | — | +29.0% |
| 44 | Kodiak Sciences Inc.KODKodiak Sciences Inc. | $6.2B | — | — | — | +487.6% |
| 45 | Belite Bio, IncBLTEBelite Bio, Inc. | $6.1B | — | — | — | +38.0% |
| 46 | Ligand Pharmaceuticals IncorporatedLGNDLigand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empo… | $6.1B | 30.7x | — | +54.9% | +47.1% |
| 47 | Mirum Pharmaceuticals, Inc.MIRMMirum Pharmaceuticals, Inc. | $6.1B | — | — | +44.0% | +38.4% |
| 48 | Veradermics, IncorporatedMANEVeradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various s… | $5.8B | — | — | — | +202.1% |
| 49 | Scholar Rock Holding CorporationSRRKScholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions… | $5.7B | — | — | — | +63.0% |
| 50 | Cogent Biosciences, Inc.COGTCogent Biosciences, Inc. | $5.5B | — | — | — | +115.0% |
| 51 | PTC Therapeutics, Inc.PTCTPTC Therapeutics, Inc. | $5.5B | — | — | −42.8% | −9.8% |
| 52 | Erasca, Inc.ERASErasca, Inc. | $5B | — | — | — | +543.3% |
| 53 | CRISPR Therapeutics AGCRSPCRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. | $4.9B | — | — | −64.2% | −11.5% |
| 54 | Edgewise Therapeutics, Inc.EWTXEdgewise Therapeutics, Inc. | $4.8B | — | — | — | +163.6% |
| 55 | Dianthus Therapeutics, Inc.DNTHDianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoim… | $4.8B | — | — | −60.8% | +136.2% |
| 56 | Travere Therapeutics, Inc.TVTXTravere Therapeutics, Inc. | $4.8B | — | — | +77.1% | +49.0% |
| 57 | Definium Therapeutics, Inc.DFTXDefinium Therapeutics, Inc. | $4.5B | — | — | — | +193.4% |
| 58 | Adaptive Biotechnologies CorporationADPTAdaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until… | $4.5B | — | — | +50.1% | +79.8% |
| 59 | Legend Biotech CorporationLEGNLegend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and co… | $4.3B | — | — | +59.5% | −27.7% |
| 60 | Relay Therapeutics, Inc.RLAYRelay Therapeutics, Inc. | $4.1B | — | — | +23.9% | +184.9% |
| 61 | AbCellera Biologics Inc.ABCLAbCellera Biologics Inc. | $3.8B | — | — | +101.3% | +162.3% |
| 62 | Xenon Pharmaceuticals Inc.XENEXenon Pharmaceuticals Inc. | $3.8B | — | — | — | +2.3% |
| 63 | Amylyx Pharmaceuticals, Inc.AMLXAmylyx Pharmaceuticals, Inc. | $3.7B | — | — | — | +136.7% |
| 64 | Acadia Pharmaceuticals Inc.ACADAcadia Pharmaceuticals Inc. | $3.7B | 9.4x | — | +11.8% | −1.9% |
| 65 | Iovance Biotherapeutics, Inc.IOVAIovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to… | $3.6B | — | — | +34.5% | +248.0% |
| 66 | Tango Therapeutics, Inc.TNGXTango Therapeutics, Inc. | $3.6B | — | — | +121.5% | +168.4% |
| 67 | Enliven Therapeutics, Inc.ELVNEnliven Therapeutics, Inc. | $3.6B | — | — | — | +170.1% |
| 68 | Parabilis Medicines, Inc.PBLSFog Pharmaceuticals, Inc. | $3.5B | — | — | — | +25.2% |
| 69 | Viking Therapeutics, Inc.VKTXViking Therapeutics, Inc. | $3.4B | — | — | — | −28.0% |
| 70 | Tarsus Pharmaceuticals, Inc.TARSTarsus Pharmaceuticals, Inc. | $3.4B | — | — | +105.2% | +0.7% |
| 71 | Dyne Therapeutics, Inc.DYNDyne Therapeutics, Inc. | $3.4B | — | — | — | −0.7% |
| 72 | Telix Pharmaceuticals LimitedTLXTelix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic… | $3.3B | 99.8x | — | +202.0% | −2.5% |
| 73 | Celcuity Inc.CELCCelcuity, Inc. | $3.3B | — | — | — | −10.0% |
| 74 | Viridian Therapeutics, Inc.VRDNViridian Therapeutics, Inc. | $3.2B | — | — | +23,220.3% | +3.6% |
| 75 | Arcutis Biotherapeutics, Inc.ARQTArcutis Biotherapeutics, Inc. | $3.2B | 115.7x | — | +76.1% | +1.8% |
| 76 | Denali Therapeutics Inc.DNLIDenali Therapeutics Inc. | $3.2B | — | — | — | +39.3% |
| 77 | Disc Medicine, Inc.IRONBased in Watertown, Massachusetts, Disc Medicine, Inc. | $3B | — | — | — | −9.3% |
| 78 | IDEAYA Biosciences, Inc.IDYAIDEAYA Biosciences, Inc. | $3B | — | — | +3,244.7% | +4.7% |
| 79 | Zai Lab LimitedZLABOperating primarily in Mainland China and Hong Kong, Zai Lab Limited is a biopharmaceutical company focused on the discovery, development, a… | $2.9B | — | — | +5.1% | +10.1% |
| 80 | ADMA Biologics, Inc.ADMAADMA Biologics, Inc. | $2.9B | 17.7x | — | +8.0% | −9.3% |
| 81 | Vericel CorporationVCELVericel Corporation operates as a biopharmaceutical firm that has reached the commercialization phase, specializing in the research, develop… | $2.8B | 113.8x | — | +23.0% | +41.0% |
| 82 | Xeris Biopharma Holdings, Inc.XERSXeris Biopharma Holdings, Inc. | $2.8B | — | — | +36.3% | +97.2% |
| 83 | Beam Therapeutics Inc.BEAMBeam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. | $2.7B | — | — | +158.9% | +14.1% |
| 84 | Xencor, Inc.XNCRXencor Inc., a biopharmaceutical firm headquartered in Monrovia, California, and established in 1997, operates as a clinical-stage entity. | $2.7B | — | — | −36.1% | +155.4% |
| 85 | Palvella Therapeutics, Inc.PVLAPalvella Therapeutics, Inc. | $2.5B | — | — | — | +123.7% |
| 86 | MBX Biosciences, Inc. Common StockMBXMBX Biosciences, Inc. | $2.5B | — | — | — | +107.6% |
| 87 | Pharvaris N.V.PHVSPharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with… | $2.4B | — | — | — | +57.8% |
| 88 | Celldex Therapeutics, Inc.CLDXCelldex Therapeutics, Inc. | $2.3B | — | — | −98.1% | +28.4% |
| 89 | Arcus Biosciences, Inc.RCUSArcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. | $2.3B | — | — | −55.3% | −6.5% |
| 90 | Hemab Therapeutics Holdings, Inc. Common StockCOAGHemab Therapeutics Holdings, Inc. | $2.3B | — | — | — | −4.4% |
| 91 | Septerna IncSEPNSepterna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule product… | $2.3B | — | — | +13,520.1% | +159.8% |
| 92 | NewAmsterdam Pharma Company N.V.NAMSNewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with car… | $2.3B | — | — | −88.9% | −49.0% |
| 93 | Immunome, Inc.IMNMImmunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-dru… | $2.2B | — | — | — | +20.7% |
| 94 | Aurinia Pharmaceuticals Inc.AUPHAurinia Pharmaceuticals Inc. | $2.2B | 7.0x | — | +19.8% | +18.0% |
| 95 | Recursion Pharmaceuticals, Inc.RXRXRecursion Pharmaceuticals, Inc. | $2.2B | — | — | −14.9% | −23.9% |
| 96 | Lakefront Biotherapeutics N.V.LKFTLakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scient… | $2.2B | 4.1x | — | +259.4% | +7.2% |
| 97 | Biohaven Ltd.BHVNBiohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuro… | $2.2B | — | — | — | +69.8% |
| 98 | Vera Therapeutics, Inc.VERAVera Therapeutics, Inc. | $2.1B | — | — | — | +18.1% |
| 99 | Maravai LifeSciences Holdings, Inc.MRVIMaravai LifeSciences Holdings, Inc. | $2.1B | — | — | −3.3% | +160.4% |
| 100 | Zymeworks Inc.ZYMEZymeworks Inc. | $2.1B | — | — | −69.8% | +65.5% |
| 101 | Fortrea Holdings Inc.FTREFortrea Holdings Inc. | $2.1B | — | — | −2.1% | +99.3% |
| 102 | Vir Biotechnology, Inc.VIRVir Biotechnology, Inc. | $2.1B | — | — | +1,495.9% | +138.4% |
| 103 | Replimune Group, Inc.REPLReplimune Group, Inc. | $2B | — | — | — | +154.4% |
| 104 | Trevi Therapeutics, Inc.TRVITrevi Therapeutics, Inc. | $2B | — | — | — | +30.2% |
| 105 | First Tracks Biotherapeutics IncTRAXFirst Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. | $2B | — | — | — | +89.7% |
| 106 | BioCryst Pharmaceuticals, Inc.BCRXBioCryst Pharmaceuticals, Inc. | $2B | — | — | +68.7% | +9.3% |
| 107 | Alamar Biosciences, Inc.ALMRAlamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of vari… | $1.9B | — | — | — | +25.9% |
| 108 | Harmony Biosciences Holdings, Inc.HRMYHarmony Biosciences Holdings, Inc. | $1.9B | 10.6x | — | +24.3% | +7.0% |
| 109 | Maze Therapeutics, Inc.MAZEMaze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney… | $1.9B | — | — | +700.0% | +15.4% |
| 110 | Sarepta Therapeutics, Inc.SRPTSarepta Therapeutics, Inc. | $1.9B | — | — | −20.4% | +1.0% |
| 111 | Mesoblast LimitedMESOMesoblast Limited is a biopharmaceutical firm dedicated to the development and commercialization of allogeneic cell-based therapies. | $1.9B | — | — | +602.3% | −4.4% |
| 112 | Zenas BioPharma, Inc.ZBIOZenas BioPharma, Inc. | $1.8B | — | — | −93.3% | −12.9% |
| 113 | Novavax, Inc.NVAXNovavax, Inc. | $1.8B | — | — | −61.6% | +42.0% |
| 114 | Agios Pharmaceuticals, Inc.AGIOAgios Pharmaceuticals, Inc. | $1.8B | — | — | +140.6% | −27.0% |
| 115 | Absci CorporationABSIAbsci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic… | $1.7B | — | — | −62.3% | +183.3% |
| 116 | Stoke Therapeutics, Inc.STOKStoke Therapeutics, Inc. | $1.7B | — | — | −86.2% | +18.1% |
| 117 | SELLAS Life Sciences Group, Inc.SLSSELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for vari… | $1.7B | — | — | — | +419.8% |
| 118 | Kailera Therapeutics, Inc.KLRAKailera Therapeutics, Inc. | $1.7B | — | — | — | −55.0% |
| 119 | Generate Biomedicines, Inc.GENBGenerate Biomedicines, Inc. | $1.7B | — | — | — | +3.2% |
| 120 | Nurix Therapeutics, Inc.NRIXNurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small… | $1.7B | 6.4x | — | +738.8% | +22.2% |
| 121 | Precigen, Inc.PGENPrecigen, Inc. | $1.6B | — | — | +1,875.0% | +14.0% |
| 122 | Immunocore Holdings plcIMCRImmunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in… | $1.6B | — | — | +13.4% | −1.9% |
| 123 | Intellia Therapeutics, Inc.NTLAIntellia Therapeutics, Inc. | $1.6B | — | — | +12.6% | −7.9% |
| 124 | Nanobiotix S.A.NBTXNanobiotix S.A. | $1.6B | — | — | −61.8% | +55.7% |
| 125 | Ultragenyx Pharmaceutical Inc.RAREUltragenyx Pharmaceutical Inc. | $1.5B | — | — | +17.5% | −50.1% |
| 126 | uniQure N.V.QUREuniQure N.V. | $1.5B | — | — | +30.2% | −21.1% |
| 127 | ADARx Pharmaceuticals, Inc.ADRXADARx Pharmaceuticals, Inc. | $1.5B | — | — | — | −7.3% |
| 128 | Damora Therapeutics, Inc.DMRADamora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North A… | $1.5B | — | — | — | +307.2% |
| 129 | Nuvation Bio Inc.NUVBNuvation Bio Inc. | $1.5B | — | — | +1,083.6% | −17.0% |
| 130 | Ocular Therapeutix, Inc.OCULOcular Therapeutix, Inc. | $1.4B | — | — | −8.1% | −37.9% |
| 131 | Ascentage Pharma Group InternationalAAPGBased in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. | $1.4B | — | — | −11.0% | −52.3% |
| 132 | Taysha Gene Therapies, Inc.TSHATaysha Gene Therapies, Inc. | $1.4B | — | — | −32.3% | +10.5% |
| 133 | AnaptysBio, Inc.ANABAnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory dise… | $1.4B | 6.9x | — | +92.9% | +82.4% |
| 134 | Kardigan, Inc.KARDKardigan, Inc. | $1.4B | — | — | — | −36.9% |
| 135 | Innoviva, Inc.INVAInnoviva, Inc. | $1.4B | 3.9x | — | +19.8% | −7.2% |
| 136 | Mineralys Therapeutics, Inc.MLYSMineralys Therapeutics, Inc. | $1.4B | — | — | — | −58.6% |
| 137 | LB Pharmaceuticals Inc Common StockLBRXThis biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuro… | $1.4B | — | — | — | +170.9% |
| 138 | Braveheart Bio, Inc.BRVEBraveheart Bio, Inc. | $1.3B | — | — | — | −34.4% |
| 139 | Avalyn Pharma Inc. Common StockAVLNAvalyn Pharma Inc. | $1.3B | — | — | — | −16.4% |
| 140 | GH Research PLCGHRSGH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions… | $1.3B | — | — | — | +38.8% |
| 141 | Alpha Tau Medical LtdDRTSAlpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffu… | $1.3B | — | — | — | +261.1% |
| 142 | Tyra Biosciences, Inc.TYRATyra Biosciences, Inc. | $1.3B | — | — | — | +48.1% |
| 143 | MannKind CorporationMNKDMannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered trea… | $1.3B | — | — | +30.5% | −31.6% |
| 144 | Inhibrx Biosciences Inc.INBXInhibrx Biosciences, Inc. | $1.2B | — | — | — | +4.4% |
| 145 | SpyGlass Pharma, Inc. Common StockSGPSpyGlass Pharma, Inc. | $1.2B | — | — | — | −6.4% |
| 146 | Omeros CorporationOMEROmeros Corporation is a biopharmaceutical firm with commercialized products, actively engaged in the discovery, development, and market intr… | $1.2B | 8.9x | — | — | +157.1% |
| 147 | COMPASS Pathways plcCMPSCOMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. | $1.2B | — | — | — | +54.0% |
| 148 | UroGen Pharma Ltd.URGNUroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty canc… | $1.2B | — | — | +100.3% | +5.2% |
| 149 | Rapport Therapeutics, Inc. Common StockRAPPRapport Therapeutics, Inc. | $1.2B | — | — | — | −3.6% |
| 150 | Structure Therapeutics Inc.GPCRStructure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creatin… | $1.2B | — | — | — | −39.2% |
| 151 | Seaport Therapeutics, Inc. Common StockSPTXSeaport Therapeutics, Inc. | $1.2B | — | — | — | −11.3% |
| 152 | Janux Therapeutics, Inc.JANXJanux Therapeutics, Inc. | $1.1B | — | — | +5,367.0% | −38.5% |
| 153 | Vor Biopharma Inc.VORVor Biopharma, Inc. | $1.1B | — | — | — | +4.8% |
| 154 | Nektar TherapeuticsNKTRNektar Therapeutics is a biopharmaceutical firm dedicated to the global discovery and advancement of therapies addressing significant unmet… | $1.1B | — | — | −27.2% | −32.4% |
| 155 | Savara Inc.SVRASavara Inc. | $992M | — | — | — | +21.4% |
| 156 | Alto Neuroscience, Inc.ANROAlto Neuroscience, Inc. | $987M | — | — | — | +126.1% |
| 157 | MoonLake ImmunotherapeuticsMLTXMoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing… | $981M | — | — | — | +12.1% |
| 158 | Jade Biosciences, Inc.JBIOJade Biosciences, Inc. | $958M | — | — | — | +68.4% |
| 159 | Immatics N.V.IMTXImmatics N.V. | $952M | — | — | −68.0% | −31.1% |
| 160 | Silence Therapeutics plcSLNSilence Therapeutics plc is a London, UK-based biotechnology company specializing in the research and development of groundbreaking ribonucl… | $932M | — | — | −97.6% | +205.9% |
| 161 | Odyssey Therapeutics, Inc.ODTXOdyssey Therapeutics, Inc. | $924M | — | — | — | +7.0% |
| 162 | ORIC Pharmaceuticals, Inc.ORICORIC Pharmaceuticals, Inc. | $914M | — | — | — | −29.7% |
| 163 | Monte Rosa Therapeutics, Inc.GLUEMonte Rosa Therapeutics, Inc. | $902M | — | — | −83.9% | −18.8% |
| 164 | Corvus Pharmaceuticals, Inc.CRVSCorvus Pharmaceuticals, Inc. | $887M | — | — | — | +34.8% |
| 165 | Pharming Group N.V.PHARPharming Group N.V. | $870M | 84.0x | — | −99.6% | −16.4% |
| 166 | MeiraGTx Holdings plcMGTXMeiraGTx Holdings plc operates as a clinical-stage gene therapy company, dedicated to pioneering therapeutic solutions for individuals affli… | $864M | 11.8x | — | +948.3% | +7.0% |
| 167 | Syndax Pharmaceuticals, Inc.SNDXSyndax Pharmaceuticals, Inc. | $859M | — | — | +222.3% | −35.1% |
| 168 | Aktis Oncology, Inc.AKTSAktis Oncology, Inc. | $850M | — | — | — | −28.5% |
| 169 | Prime Medicine, Inc.PRMEPrime Medicine, Inc. | $843M | — | — | −17.9% | +11.2% |
| 170 | Lexicon Pharmaceuticals, Inc.LXRXLexicon Pharmaceuticals, Inc. | $792M | — | — | −29.0% | +24.5% |
| 171 | Alumis Inc.ALMSAlumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disord… | $780M | — | — | −63.1% | +27.8% |
| 172 | Verastem, Inc.VSTMVerastem, Inc. | $762M | — | — | +3,995.7% | +6.1% |
| 173 | Ginkgo Bioworks Holdings, Inc.DNAGinkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. | $760M | — | — | −51.5% | −0.1% |
| 174 | Rigel Pharmaceuticals, Inc.RIGLRigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic di… | $741M | 2.2x | — | +3.3% | +9.8% |
| 175 | OmniAb, Inc.OABIOmniAb, Inc. | $734M | — | — | +66.9% | +264.5% |
| 176 | Arbutus Biopharma CorpABUSArbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United… | $724M | 4.6x | — | +1,078.8% | −17.7% |
| 177 | Ardelyx, Inc.ARDXArdelyx, Inc. | $718M | — | — | +16.8% | −49.0% |
| 178 | Sana Biotechnology, Inc.SANASana Biotechnology, Inc. | $709M | — | — | — | −41.4% |
| 179 | Solid Biosciences Inc.SLDBSolid Biosciences Inc. | $707M | — | — | — | +56.2% |
| 180 | Attovia Therapeutics, Inc.ATTOA clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. | $697M | — | — | — | −32.5% |
| 181 | Cullinan Therapeutics, Inc.CGEMCullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United… | $695M | — | — | — | +53.9% |
| 182 | Achieve Life Sciences, Inc.ACHVAchieve Life Sciences, Inc. | $692M | — | — | — | +41.8% |
| 183 | Zevra Therapeutics, Inc.ZVRAZevra Therapeutics, Inc., founded in 2006 and based in Celebration, Florida, is a biopharmaceutical company dedicated to discovering and dev… | $688M | 12.1x | — | +119.4% | +27.5% |
| 184 | Annexon, Inc.ANNXAnnexon, Inc. | $688M | — | — | — | +39.1% |
| 185 | Nuvectis Pharma, Inc.NVCTNuvectis Pharma, Inc. | $683M | — | — | — | +268.8% |
| 186 | Aura Biosciences, Inc.AURAHeadquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. | $680M | — | — | — | +21.3% |
| 187 | 4D Molecular Therapeutics, Inc.FDMT4D Molecular Therapeutics, Inc. | $677M | — | — | +278,712.1% | +12.2% |
| 188 | ArriVent BioPharma, Inc.AVBPArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of m… | $673M | — | — | — | −25.8% |
| 189 | Candel Therapeutics, Inc.CADLCandel Therapeutics, Inc. | $670M | — | — | — | +77.1% |
| 190 | Immix Biopharma, Inc.IMMXImmix Biopharma, Inc. | $668M | — | — | — | +166.0% |
| 191 | Wave Life Sciences Ltd.WVEWave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines thro… | $664M | — | — | −30.4% | −57.3% |
| 192 | Kura Oncology, Inc.KURAKura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. | $647M | — | — | −7.3% | −28.4% |
| 193 | Olema Pharmaceuticals, Inc.OLMAOlema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and c… | $641M | — | — | — | −10.5% |
| 194 | Design Therapeutics, Inc.DSGNDesign Therapeutics, Inc. | $639M | — | — | — | +48.6% |
| 195 | Geron CorporationGERNGeron Corporation is an advanced-stage biopharmaceutical company dedicated to the creation and market introduction of treatments for myeloid… | $636M | — | — | +24.4% | −8.4% |
| 196 | Apnimed, Inc.APMDApnimed, Inc. | $629M | — | — | — | +14.0% |
| 197 | Climb Bio, Inc.CLYMClimb Bio, Inc. | $591M | — | — | — | +427.7% |
| 198 | Aclaris Therapeutics, Inc.ACRSAclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused… | $574M | — | — | −51.0% | +71.8% |
| 199 | Bicara Therapeutics Inc. Common StockBCAXBicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. | $572M | — | — | — | −40.6% |
| 200 | Faeth Therapeutics, Inc.FTHFaeth Therapeutics, Inc. | $568M | — | — | — | +136.1% |
| 201 | Ovid Therapeutics Inc.OVIDOvid Therapeutics Inc. | $557M | — | — | −76.2% | +114.3% |
| 202 | Entera Bio Ltd.ENTXEntera Bio Ltd. | $546M | — | — | — | +1.0% |
| 203 | Adlai Nortye Ltd.ANLAdlai Nortye Ltd. | $546M | — | — | — | +563.2% |
| 204 | SL Science Holding LtdSLBTSL Science Holding Limited manufactures cosmetic skin care and scalp care products. | $526M | — | — | — | −80.2% |
| 205 | Capricor Therapeutics, Inc.CAPRCapricor Therapeutics, Inc. | $521M | — | — | — | +43.3% |
| 206 | Valneva SEVALNValneva SE operates as a specialized biopharmaceutical company, concentrating its efforts on developing and bringing to market preventative… | $518M | — | — | −26.9% | −38.1% |
| 207 | DiaMedica Therapeutics Inc.DMACDiaMedica Therapeutics Inc. | $505M | — | — | — | +50.5% |
| 208 | Gyre Therapeutics, Inc.GYREGyre Therapeutics, Inc. | $505M | — | — | +13.5% | −35.1% |
| 209 | REGENXBIO Inc.RGNXREGENXBIO Inc. | $503M | — | — | +12.0% | −31.8% |
| 210 | Crescent Biopharma, Inc.CBIOCrescent Biopharma, Inc. | $503M | — | — | — | +3.4% |
| 211 | MiMedx Group, Inc.MDXGMiMedx Group, Inc. | $483M | 82.8x | — | −2.4% | −54.8% |
| 212 | Monopar Therapeutics Inc.MNPRMonopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the… | $479M | — | — | — | −11.6% |
| 213 | CytomX Therapeutics, Inc.CTMXCytomX Therapeutics, Inc. | $477M | — | — | −87.0% | −47.7% |
| 214 | Shattuck Labs, Inc.STTKShattuck Labs, Inc. | $464M | — | — | −66.6% | +135.7% |
| 215 | Oculis Holding AGOCSOculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medi… | $462M | — | — | −6.9% | −61.4% |
| 216 | Eupraxia Pharmaceuticals Inc.EPRXEupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas w… | $455M | — | — | — | +23.5% |
| 217 | Phathom Pharmaceuticals, Inc.PHATPhathom Pharmaceuticals, Inc. | $427M | — | — | +110.2% | −59.7% |
| 218 | Puma Biotechnology, Inc.PBYIPuma Biotechnology, Inc. | $426M | 15.4x | — | −2.9% | +68.4% |
| 219 | YD Bio Limited Ordinary SharesYDESYD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commer… | $423M | — | — | — | −36.6% |
| 220 | Arvinas, Inc.ARVNArvinas, Inc. | $419M | 34.2x | — | −15.0% | −35.9% |
| 221 | Relmada Therapeutics, Inc.RLMDRelmada Therapeutics, Inc. | $416M | — | — | — | +49.4% |
| 222 | Assembly Biosciences, Inc.ASMBAssembly Biosciences, Inc. | $416M | 37.1x | — | +125.1% | −34.6% |
| 223 | CorMedix Inc.CRMDCorMedix Inc. | $415M | 2.2x | — | +280.5% | −50.6% |
| 224 | Prothena Corporation plcPRTAProthena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat dise… | $409M | — | — | +427.3% | −20.9% |
| 225 | Altimmune, Inc.ALTAltimmune, Inc. | $405M | — | — | +55.0% | −47.2% |
| 226 | Tectonic Therapeutic, Inc.TECXTectonic Therapeutic, Inc. | $403M | — | — | — | +8.7% |
| 227 | Neurogene Inc.NGNENeurogene Inc. | $400M | — | — | — | −5.1% |
| 228 | Editas Medicine, Inc.EDITEditas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of s… | $395M | — | — | +20.8% | −4.5% |
| 229 | Zura Bio LimitedZURAZura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic s… | $394M | — | — | — | +17.5% |
| 230 | BlossomHill Therapeutics, Inc.BLSMBlossomhill Therapeutics, Inc. | $393M | — | — | — | −6.4% |
| 231 | ProKidney Corp.PROKProKidney Corp. | $383M | — | — | +55.2% | −59.4% |
| 232 | C4 Therapeutics, Inc.CCCCC4 Therapeutics, Inc. | $381M | — | — | +2.3% | +30.3% |
| 233 | AgomAb Therapeutics N.V. American Depositary SharesAGMBAgomAb Therapeutics N.V. | $376M | — | — | — | −43.1% |
| 234 | Indaptus Therapeutics, Inc.INDPIndaptus Therapeutics, Inc. | $376M | — | — | — | +23.9% |
| 235 | Rezolute, Inc.RZLTRezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism… | $375M | — | — | — | −59.6% |
| 236 | Avalo Therapeutics, Inc.AVTXAvalo Therapeutics, Inc. | $372M | — | — | −86.6% | −55.1% |
| 237 | Lyell Immunopharma, Inc.LYELLyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for pati… | $364M | — | — | −55.0% | −16.9% |
| 238 | Allogene Therapeutics, Inc.ALLOAllogene Therapeutics, Inc. | $359M | — | — | — | −1.0% |
| 239 | Opus Genetics, Inc.IRDOpus Genetics, Inc. | $348M | — | — | −36.1% | +105.9% |
| 240 | Atea Pharmaceuticals, Inc.AVIRAtea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics… | $346M | — | — | — | +32.6% |
| 241 | Fennec Pharmaceuticals Inc.FENCFennec Pharmaceuticals Inc. | $344M | — | — | +77.8% | +22.6% |
| 242 | Orchestra BioMed Holdings, Inc.OBIOOrchestra BioMed Holdings, Inc. | $341M | — | — | +986.1% | +49.1% |
| 243 | Autolus Therapeutics plcAUTLAutolus Therapeutics plc is a clinical-stage biopharmaceutical entity primarily focused on pioneering T-cell-based immunotherapies for vario… | $341M | — | — | +292.0% | −5.9% |
| 244 | Contineum Therapeutics, Inc.CTNMContineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for n… | $337M | — | — | — | −13.5% |
| 245 | Benitec Biopharma Inc.BNTCBenitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. | $333M | — | — | — | −20.5% |
| 246 | Agenus Inc.AGENAgenus Inc. | $323M | 2.6x | — | +30.5% | +86.2% |
| 247 | Sagimet Biosciences Inc.SGMTSagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibito… | $321M | — | — | — | +28.1% |
| 248 | Enanta Pharmaceuticals, Inc.ENTAEnanta Pharmaceuticals, Inc. | $320M | — | — | +0.7% | +1.9% |
| 249 | Eikon Therapeutics, Inc. Common StockEIKNEikon Therapeutics, Inc. | $319M | — | — | — | −49.7% |
| 250 | X4 Pharmaceuticals, Inc.XFORX4 Pharmaceuticals, Inc. | $315M | — | — | −51.6% | −9.4% |
| 251 | Ocugen, Inc.OCGNOcugen, Inc. | $314M | — | — | −3.7% | −33.0% |
| 252 | Century Therapeutics, Inc.IPSCCentury Therapeutics, Inc. | $304M | — | — | — | +211.1% |
| 253 | Kyverna Therapeutics, Inc.KYTXKyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune di… | $302M | — | — | — | −31.2% |
| 254 | MapLight Therapeutics, Inc.MPLTMapLight Therapeutics, Inc. | $295M | — | — | — | −57.1% |
| 255 | Arcturus Therapeutics Holdings Inc.ARCTArcturus Therapeutics Holdings Inc. | $294M | — | — | −79.1% | +24.8% |
| 256 | Vicore Pharma Holding ABVCREVicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and… | $294M | — | — | −57.1% | −44.1% |
| 257 | Precision BioSciences, Inc.DTILPrecision BioSciences, Inc. | $293M | — | — | +3,473.0% | +64.6% |
| 258 | Turn Therapeutics Inc.TTRXTurn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments… | $288M | — | — | — | +123.1% |
| 259 | Nautilus Biotechnolgy, Inc.NAUTNautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unloc… | $284M | — | — | — | +47.7% |
| 260 | Fulcrum Therapeutics, Inc.FULCFulcrum Therapeutics, Inc. | $282M | — | — | — | −51.6% |
| 261 | ARS Pharmaceuticals, Inc.SPRYARS Pharmaceuticals, Inc. | $277M | — | — | +4.1% | −66.0% |
| 262 | SAB Biotherapeutics, Inc.SABSSAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic anti… | $276M | 0.8x | — | — | −2.3% |
| 263 | Q32 Bio Inc.QTTBOperating as a clinical-stage biotechnology firm, Q32 Bio Inc. | $275M | 3.3x | — | — | +298.7% |
| 264 | Rocket Pharmaceuticals, Inc.RCKTRocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene the… | $262M | — | — | — | −26.2% |
| 265 | Vogenx Inc.VOGXVogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of ser… | $259M | — | — | — | +23.5% |
| 266 | Lineage Cell Therapeutics, Inc.LCTXLineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical cond… | $258M | — | — | +19.9% | −41.0% |
| 267 | Alector, Inc.ALECAlector, Inc. | $256M | — | — | −82.9% | +76.2% |
| 268 | CAMP4 Therapeutics CorporationCAMPCAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. | $255M | — | — | +40.2% | −8.8% |
| 269 | Scribe Therapeutics Inc.SCTXScribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. | $254M | — | — | — | −4.3% |
| 270 | DBV Technologies S.A.DBVTDBV Technologies S.A., a biopharmaceutical firm based in Montrouge, France, operates at the clinical stage, focusing on the research and dev… | $250M | — | — | — | −25.6% |
| 271 | Bicycle Therapeutics plcBCYCBicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. | $249M | — | — | +217.4% | −44.5% |
| 272 | Larimar Therapeutics, Inc.LRMRHeadquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. | $248M | — | — | — | −31.1% |
| 273 | Evommune, Inc.EVMNEvommune, Inc. | $241M | — | — | — | −67.1% |
| 274 | Abeona Therapeutics Inc.ABEOAbeona Therapeutics Inc. | $238M | — | — | +6,280.0% | −0.5% |
| 275 | Immuneering CorporationIMRXImmuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cance… | $238M | — | — | — | −44.4% |
| 276 | Lexeo Therapeutics, Inc. Common StockLXEOLexeo Therapeutics, Inc. | $237M | — | — | — | −65.7% |
| 277 | Surrozen, Inc.SRZNSurrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. | $232M | — | — | −8.8% | +148.0% |
| 278 | Vanda Pharmaceuticals Inc.VNDAVanda Pharmaceuticals Inc. | $231M | — | — | +6.0% | −13.4% |
| 279 | Cartesian Therapeutics, Inc.RNACCartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. | $228M | — | — | +44.0% | −0.3% |
| 280 | AC Immune S.A.ACIUAC Immune S.A. | $227M | — | — | −39.5% | −35.4% |
| 281 | Bright Minds Biosciences Inc.DRUGBright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering… | $227M | — | — | — | −59.0% |
| 282 | Greenwich LifeSciences, Inc.GLSIGreenwich LifeSciences, Inc. | $223M | — | — | — | +84.5% |
| 283 | Cabaletta Bio, Inc.CABACabaletta Bio, Inc. | $220M | — | — | — | −47.6% |
| 284 | Korro Bio, Inc.KRROKorro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market ge… | $217M | — | — | −62.1% | −54.7% |
| 285 | Fate Therapeutics, Inc.FATEFate Therapeutics, Inc. | $214M | — | — | −23.4% | +76.4% |
| 286 | Eledon Pharmaceuticals, Inc.ELDNEledon Pharmaceuticals, Inc. | $212M | — | — | — | −36.5% |
| 287 | Inhibikase Therapeutics, Inc.IKTInhibikase Therapeutics, Inc. | $209M | — | — | — | +0.7% |
| 288 | Prelude Therapeutics IncorporatedPRLDPrelude Therapeutics, Inc. | $208M | — | — | +220.3% | +166.7% |
| 289 | Galectin Therapeutics Inc.GALTGalectin Therapeutics Inc. | $207M | — | — | — | −43.7% |
| 290 | Protalix BioTherapeutics, Inc.PLXProtalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant th… | $205M | 10.5x | — | +30.1% | +14.4% |
| 291 | Artiva Biotherapeutics, Inc.ARTVArtiva Biotherapeutics, Inc. | $203M | — | — | — | +20.6% |
| 292 | ADC Therapeutics S.A.ADCTADC Therapeutics S.A. | $202M | — | — | +2.0% | −62.0% |
| 293 | BioAge Labs Inc.BIOABioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. | $201M | — | — | +168.1% | −28.5% |
| 294 | Sol-Gel Technologies Ltd.SLGLSol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introdu… | $200M | — | — | −92.5% | +90.6% |
| 295 | Inventiva S.A.IVAInventiva S.A. | $198M | — | — | −70.3% | −9.1% |
| 296 | Palisade Bio, Inc.PALIPalisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed f… | $197M | — | — | — | −31.9% |
| 297 | InflaRx N.V.IFRXInflaRx N.V. | $192M | — | — | −106.2% | +8.8% |
| 298 | ProQR Therapeutics N.V.PRQRProQR Therapeutics N.V. | $191M | — | — | +12.7% | −38.9% |
| 299 | Entrada Therapeutics, Inc.TRDAEntrada Therapeutics, Inc. | $190M | — | — | −94.1% | −29.6% |
| 300 | Compugen Ltd.CGENCompugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discov… | $186M | 5.2x | — | +234.2% | +19.5% |
| 301 | Keros Therapeutics, Inc.KROSKeros Therapeutics, Inc., a biopharmaceutical entity in the clinical development phase, is focused on pioneering and commercializing innovat… | $186M | — | — | −93.6% | −42.1% |
| 302 | MediWound Ltd.MDWDMediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions f… | $184M | — | — | −40.3% | −21.0% |
| 303 | Whitehawk Therapeutics IncWHWKWhitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cance… | $178M | — | — | — | +49.0% |
| 304 | Upstream Bio, Inc.UPBUpstream Bio, Inc. | $177M | — | — | +16.0% | −86.3% |
| 305 | PepGen Inc.PEPGPepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neu… | $171M | — | — | — | −41.3% |
| 306 | Invivyd, Inc.IVVDAdagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in th… | $166M | — | — | +26.3% | −63.4% |
| 307 | Canton Strategic Holdings IncCNTNCanton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. | $164M | — | — | — | −50.4% |
| 308 | Niagen Bioscience IncNAGENiagen Bioscience, Inc. | $164M | 10.7x | — | +11.0% | −68.6% |
| 309 | BridgeBio Oncology Therapeutics Inc.BBOTBridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for… | $164M | — | — | — | −83.3% |
| 310 | Innate Pharma S.A.IPHAInnate Pharma S.A. | $161M | — | — | −91.4% | −20.0% |
| 311 | Oramed Pharmaceuticals Inc.ORMPOramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutica… | $161M | 0.9x | 6.48% | — | +88.3% |
| 312 | ALX Oncology Holdings Inc.ALXOALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United Stat… | $160M | — | — | — | −2.1% |
| 313 | Sutro Biopharma, Inc.STROSutro Biopharma, Inc. | $160M | — | — | −56.3% | +2.1% |
| 314 | AN2 Therapeutics, Inc.ANTXAN2 Therapeutics, Inc. | $151M | — | — | — | +257.1% |
| 315 | MacroGenics, Inc.MGNXMacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeu… | $148M | — | — | +2.3% | +71.3% |
| 316 | Sionna Therapeutics, Inc.SIONSionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosi… | $148M | — | — | — | −90.5% |
| 317 | Korsana Biosciences, Inc.KRSACyclerion Therapeutics, Inc. | $145M | — | — | −12.6% | +162.5% |
| 318 | Yarrow Bioscience IncYARWYarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. | $145M | — | 128.85% | +1.3% | −11.0% |
| 319 | NervGen Pharma Corp. Common stockNGENNervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to… | $143M | — | — | — | −62.1% |
| 320 | Atrium Therapeutics, Inc.RNAAtrium Therapeutics, Inc. | $143M | — | — | — | −47.0% |
| 321 | Jyong Biotech Ltd. Ordinary SharesMENSJyong Biotech Ltd. | $137M | — | — | — | −95.2% |
| 322 | Compass Therapeutics, Inc.CMPXCompass Therapeutics, Inc. | $137M | — | — | — | −81.0% |
| 323 | Cue Biopharma, Inc.CUECue Biopharma, Inc. | $136M | — | — | +354.4% | −12.8% |
| 324 | Protara Therapeutics, Inc.TARAProtara Therapeutics, Inc. | $136M | — | — | — | −46.4% |
| 325 | Veraxa Biotech Holding AGVRXAVeraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. | $134M | — | — | — | −91.0% |
| 326 | Spruce Biosciences, Inc.SPRBSpruce Biosciences, Inc., founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. | $134M | — | — | — | −61.0% |
| 327 | MaxCyte, Inc.MXCTMaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. | $130M | — | — | −13.2% | −14.3% |
| 328 | Alpha Cognition IncACOGAlpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative di… | $129M | — | — | +232.7% | +45.4% |
| 329 | Armata Pharmaceuticals, Inc.ARMPArmata Pharmaceuticals, Inc. | $128M | — | — | −52.0% | −40.1% |
| 330 | PolyPid Ltd.PYPDPolyPid Ltd. | $125M | — | — | — | +61.6% |
| 331 | Humacyte, Inc.HUMAHumacyte, Inc. | $125M | — | — | −73.6% | −65.8% |
| 332 | Nkarta, Inc.NKTXNkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmun… | $124M | — | — | — | −12.2% |
| 333 | Zentalis Pharmaceuticals, Inc.ZNTLZentalis Pharmaceuticals, Inc. | $122M | — | — | — | +32.3% |
| 334 | Molecular Partners AGMOLNMolecular Partners AG operates as a clinical-stage biopharmaceutical company, specializing in the identification, advancement, and commercia… | $120M | — | — | — | −32.8% |
| 335 | Coherus Oncology, Inc.CHRSCoherus Oncology, Inc. | $119M | — | — | −64.3% | −48.3% |
| 336 | Codexis, Inc.CDXSCodexis, Inc. | $118M | — | — | +35.9% | −47.1% |
| 337 | enGene Holdings Inc.ENGNOperating through its subsidiary, enGene, Inc., enGene Holdings Inc. | $117M | — | — | — | −70.9% |
| 338 | OnKure Therapeutics, Inc.OKUROnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation… | $116M | — | — | — | −9.3% |
| 339 | Minerva Neurosciences, Inc.NERVMinerva Neurosciences, Inc. | $116M | — | — | — | −33.5% |
| 340 | Voyager Therapeutics, Inc.VYGRVoyager Therapeutics, Inc. | $115M | — | — | −19.1% | −55.8% |
| 341 | Akebia Therapeutics, Inc.AKBAAkebia Therapeutics, Inc., established in 2007 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on disc… | $111M | — | — | +7.5% | −80.0% |
| 342 | Foghorn Therapeutics Inc.FHTXFoghorn Therapeutics Inc. | $111M | — | — | +52.0% | −53.2% |
| 343 | Anixa Biosciences, Inc.ANIXAnixa Biosciences, Inc. | $110M | — | — | — | −21.8% |
| 344 | LENZ Therapeutics, Inc.LENZLENZ Therapeutics, Inc. | $110M | — | — | +329.5% | −84.8% |
| 345 | Cellectis S.A.CLLSCellectis S.A. | $108M | — | — | +0.5% | −65.8% |
| 346 | Anavex Life Sciences Corp.AVXLOperating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. | $107M | — | — | — | −84.5% |
| 347 | Outlook Therapeutics, Inc.OTLKOutlook Therapeutics, Inc. | $106M | — | — | −177.3% | −63.0% |
| 348 | Immunic, Inc.IMUXImmunic, Inc. | $106M | — | — | — | +10.6% |
| 349 | Pyxis Oncology, Inc.PYXSPyxis Oncology, Inc. | $105M | — | — | +291.4% | −58.9% |
| 350 | NovaBridge BiosciencesNBPNovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the Unit… | $105M | — | — | — | −78.3% |
| 351 | TuHURA Biosciences, Inc.HURATuHURA Biosciences, Inc. | $104M | — | — | — | −33.5% |
| 352 | NRx Pharmaceuticals, Inc.NRXPNRx Pharmaceuticals, Inc. | $103M | — | — | — | −10.9% |
| 353 | Neonc Technologies Holdings, Inc.NTHINeOnc Technologies Holdings, Inc. | $101M | — | — | — | −64.6% |
| 354 | Black Diamond Therapeutics, Inc.BDTXBlack Diamond Therapeutics, Inc. | $99.4M | — | — | — | −56.4% |
| 355 | Unicycive Therapeutics, Inc.UNCYUnicycive Therapeutics, Inc. | $97.2M | — | — | — | −20.8% |
| 356 | Vivani Medical, Inc.VANIVivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants tha… | $96.5M | — | — | — | −27.2% |
| 357 | Equillium, Inc.EQEquillium, Inc. | $95.7M | — | — | — | +19.8% |
| 358 | Milestone Pharmaceuticals Inc.MISTMilestone Pharmaceuticals Inc. | $95M | — | — | — | −55.7% |
| 359 | Neumora Therapeutics, Inc. Common StockNMRANeumora Therapeutics, Inc. | $94.6M | — | — | — | −80.5% |
| 360 | Polaryx Therapeutics, Inc. Common StockPLYXPolaryx Therapeutics, Inc. | $91.7M | — | — | — | −94.4% |
| 361 | Seer, Inc.SEERSeer, Inc. | $90.3M | — | — | −13.3% | −24.5% |
| 362 | Cibus, Inc.CBUSCibus, Inc. | $90.2M | — | — | −6.0% | −5.6% |
| 363 | ImmuCell CorporationICCCImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerin… | $89M | 115.8x | — | +8.5% | +55.3% |
| 364 | Genelux CorporationGNLXGenelux Corporation is a clinical-stage biopharmaceutical company focused on pioneering advanced oncolytic viral immunotherapies for patient… | $88.7M | — | — | — | −63.0% |
| 365 | Tiziana Life Sciences LtdTLSATiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments,… | $87.7M | — | — | — | −61.7% |
| 366 | Rallybio CorporationRLYBRallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for ind… | $84.8M | 2.0x | — | −15.1% | +208.2% |
| 367 | Inovio Pharmaceuticals, Inc.INOInovio Pharmaceuticals, Inc. | $83.9M | — | — | — | −46.0% |
| 368 | vTv Therapeutics Inc.VTVTvTv Therapeutics Inc. | $83.2M | — | — | +216,600.0% | −17.4% |
| 369 | Tenaya Therapeutics, Inc.TNYATenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the Unit… | $82.1M | — | — | — | −73.3% |
| 370 | Tonix Pharmaceuticals Holding Corp.TNXPTonix Pharmaceuticals Holding Corp. | $81.3M | — | — | +196.0% | −72.8% |
| 371 | Atara Biotherapeutics, Inc.ATRAFounded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. | $79M | — | — | −96.7% | −33.4% |
| 372 | NeurAxis, Inc.NRXSNeurAxis, Inc. | $78.4M | — | — | +65.2% | +146.6% |
| 373 | Adagene Inc.ADAGAdagene Inc. | $75.3M | — | — | +1,054.7% | +24.2% |
| 374 | OKYO Pharma LimitedOKYOOKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for indivi… | $75M | — | — | — | −45.6% |
| 375 | MediciNova, Inc.MNOVMediciNova, Inc. | $71.9M | — | — | +583.9% | +4.3% |
| 376 | Coya Therapeutics, Inc.COYACoya Therapeutics, Inc. | $70.1M | — | — | +1,793.8% | −48.1% |
| 377 | Conexeu Sciences Inc.CNXUConexeu Sciences Inc. | $69.7M | — | — | — | −69.8% |
| 378 | Acrivon Therapeutics, Inc. Common StockACRVAcrivon Therapeutics, Inc. | $69M | — | — | — | −19.5% |
| 379 | PDS Biotechnology CorporationPDSBPDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies… | $68.7M | — | — | — | +38.4% |
| 380 | Nutriband Inc.NTRBNutriband Inc. | $67.5M | — | — | −37.3% | +0.4% |
| 381 | PMV Pharmaceuticals, Inc.PMVPPMV Pharmaceuticals, Inc. | $67.2M | — | — | — | +0.8% |
| 382 | Champions Oncology, Inc.CSBRChampions Oncology, Inc. | $66.7M | — | — | +6.7% | −30.4% |
| 383 | MAIA Biotechnology, Inc.MAIAMAIA Biotechnology, Inc. | $65.4M | — | — | — | −3.6% |
| 384 | Cognition Therapeutics, Inc.CGTXCognition Therapeutics, Inc. | $65.3M | — | — | — | −58.6% |
| 385 | Cingulate Inc.CINGCingulate Inc. | $61.9M | — | — | — | +15.8% |
| 386 | Cardiff Oncology, Inc.CRDFCardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United… | $61.9M | — | — | −7.0% | −64.7% |
| 387 | Fortress Biotech, Inc.FBIOFortress Biotech, Inc. | $61.7M | 0.6x | — | +15.5% | −26.6% |
| 388 | Spero Therapeutics, Inc.SPROSpero Therapeutics, Inc. | $60M | 7.4x | — | −7.0% | −56.9% |
| 389 | Gossamer Bio, Inc.GOSSGossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of p… | $59.7M | — | — | +32.4% | −94.7% |
| 390 | Corbus Pharmaceuticals Holdings, Inc.CRBPCorbus Pharmaceuticals Holdings, Inc. | $59.4M | — | — | — | −70.6% |
| 391 | XBiotech Inc.XBITXBiotech Inc. | $57.6M | — | — | — | −20.9% |
| 392 | Kalaris Therapeutics IncKLRSKalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for p… | $57.6M | — | — | — | −48.8% |
| 393 | Xilio Therapeutics, Inc.XLOXilio Therapeutics, Inc. | $56.7M | — | — | +327.3% | −25.9% |
| 394 | Clene Inc.CLNNClene Inc. | $56.1M | — | — | −31.1% | −57.3% |
| 395 | Boundless Bio, Inc.BOLDBoundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significan… | $56M | — | — | — | +95.2% |
| 396 | Heron Therapeutics, Inc.HRTXHeron Therapeutics, Inc. | $55.6M | — | — | +1.0% | −73.4% |
| 397 | Apollomics, Inc.APLMApollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and dev… | $55.4M | — | — | +660.3% | +42.6% |
| 398 | Alps Group IncALPSAlps Group Inc. | $54.9M | — | — | — | −62.0% |
| 399 | Verrica Pharmaceuticals Inc.VRCAVerrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the tr… | $54.8M | — | — | +106.2% | −10.9% |
| 400 | Rein Therapeutics Inc.RNTXRein Therapeutics Inc. | $52.9M | — | — | — | −60.7% |
| 401 | MiNK Therapeutics, Inc.INKTMiNK Therapeutics, Inc. | $52.8M | — | — | — | −24.2% |
| 402 | Telomir Pharmaceuticals, Inc. Common StockTELOTelomir Pharmaceuticals, Inc. | $52.3M | — | — | — | −47.4% |
| 403 | RenovoRx, Inc.RNXTRenovoRx, Inc. | $51M | — | — | +198.5% | +17.0% |
| 404 | Pliant Therapeutics, Inc.PLRXPliant Therapeutics, Inc. | $50.1M | — | — | — | −47.1% |
| 405 | MindWalk Holdings Corp.HYFTMindWalk Holdings Corp. | $49.9M | — | — | −14.7% | −37.6% |
| 406 | Werewolf Therapeutics, Inc.HOWLWerewolf Therapeutics, Inc. | $49.1M | — | — | — | −15.8% |
| 407 | Dogwood Therapeutics, Inc.DWTXDogwood Therapeutics, Inc. | $48.9M | — | — | — | −75.4% |
| 408 | Caribou Biosciences, Inc.CRBUCaribou Biosciences, Inc. | $48.1M | — | — | +10.0% | −79.0% |
| 409 | iBio, Inc.IBIOiBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators a… | $47.5M | — | — | −75.0% | −46.9% |
| 410 | OS Therapies IncorporatedOSTXOS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of… | $46.8M | — | — | — | −45.1% |
| 411 | ImageneBio IncIMAImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflamma… | $46.6M | — | — | — | −51.1% |
| 412 | Instil Bio, Inc.TILInstil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. | $46.3M | — | — | — | −54.5% |
| 413 | Connect Biopharma Holdings LimitedCNTBConnect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. | $45.9M | — | — | −84.7% | −56.1% |
| 414 | Mereo BioPharma Group plcMREOMereo BioPharma Group plc, a London-based biopharmaceutical firm established in 2015, specializes in developing and commercializing innovati… | $45.2M | — | — | — | −83.9% |
| 415 | Actinium Pharmaceuticals, Inc.ATNMActinium Pharmaceuticals, Inc. | $45M | 4.0x | — | — | +8.3% |
| 416 | Tenax Therapeutics, Inc.TENXTenax Therapeutics, Inc. | $44.8M | — | — | — | −75.6% |
| 417 | NOMAD Power Solutions, Inc.NMADNOMAD Power Solutions, Inc., through its wholly owned subsidiary NOMAD Transportable Power Systems, provides transportable, utility-grade ba… | $44.5M | — | — | — | −38.5% |
| 418 | Oncolytics Biotech Inc.ONCYOncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology… | $44.1M | — | — | — | −56.5% |
| 419 | Gain Therapeutics, Inc.GANXGain Therapeutics, Inc. | $43.9M | — | — | — | −45.8% |
| 420 | Eloxx Pharmaceuticals, Inc.ELOXEloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modul… | $42.7M | — | — | — | +24.4% |
| 421 | Alterity Therapeutics LimitedATHEAlterity Therapeutics Limited, an Australian biopharmaceutical firm, focuses on the discovery and development of novel drug treatments for v… | $41.2M | — | — | −31.5% | −30.6% |
| 422 | Biomea Fusion, Inc.BMEABiomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to trea… | $41M | — | — | — | −56.4% |
| 423 | eXoZymes, Inc.EXOZeXoZymes, Inc. | $40.8M | — | — | — | −67.4% |
| 424 | Aldeyra TheALDXAldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. | $38.2M | — | — | — | −86.8% |
| 425 | ProMIS Neurosciences, Inc.PMNProMIS Neurosciences, Inc. | $37.3M | — | — | — | −57.4% |
| 426 | Elutia IncELUTElutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and relate… | $37.1M | 0.6x | — | −48.8% | −11.1% |
| 427 | Veru Inc.VERUVeru Inc. | $36.1M | — | — | — | −15.9% |
| 428 | Annovis Bio, Inc.ANVSAnnovis Bio, Inc. | $36.1M | — | — | — | −57.5% |
| 429 | Pelthos Therapeutics Inc.PTHSPelthos Therapeutics Inc. | $35.8M | — | — | — | −75.0% |
| 430 | Rani Therapeutics Holdings, Inc.RANIRani Therapeutics Holdings, Inc. | $35.7M | — | — | +306.4% | −75.9% |
| 431 | Impact BioMedical Inc.IBOHouston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic opti… | $35.5M | — | — | +400.0% | −39.0% |
| 432 | GridAI Technologies Corp.GRDXGridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device p… | $35.1M | — | — | — | +42.2% |
| 433 | BriaCell Therapeutics Corp.BCTXBriaCell Therapeutics Corp. | $34.5M | — | — | — | −59.8% |
| 434 | NanoViricides, Inc.NNVCNanoViricides, Inc. | $33.7M | — | — | — | −30.5% |
| 435 | IRulya Therapeutics Inc.IRLAIRulya Therapeutics is a clinical-stage biopharmaceutical company developing LAM-001, an inhaled formulation of rapamycin, for pulmonary dis… | $31.5M | — | — | — | −90.3% |
| 436 | INmune Bio, Inc.INMBINmune Bio, Inc. | $31.4M | — | — | — | −30.7% |
| 437 | Lite Strategy, Inc.LITSLite Strategy, Inc. | $31M | — | — | — | −44.6% |
| 438 | EyePoint Pharmaceuticals, Inc.EYPTEyePoint Pharmaceuticals, Inc. | $30.2M | — | — | −94.6% | −96.8% |
| 439 | Grace Therapeutics, Inc.GRCEGrace Therapeutics, Inc. | $30.1M | — | — | — | −39.1% |
| 440 | Elicio Therapeutics, Inc.ELTXElicio Therapeutics, Inc. | $28.8M | — | — | — | −83.4% |
| 441 | Adicet Bio, Inc.ACETAdicet Bio, Inc. | $28.6M | — | — | — | −71.8% |
| 442 | Incannex Healthcare LimitedIXHLIncannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid… | $26.8M | — | — | — | −79.5% |
| 443 | Metagenomi, Inc. Common StockMGXMetagenomi, Inc. | $26.8M | — | — | −59.8% | −68.0% |
| 444 | ABVC BioPharma, Inc.ABVCABVC BioPharma, Inc. | $25.9M | — | — | −303.4% | −65.9% |
| 445 | Aardvark Therapeutics, Inc. Common StockAARDAardvark Therapeutics, Inc. | $25.6M | — | — | — | −88.1% |
| 446 | CEL-SCI CorporationCVMCEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases… | $25.5M | — | — | — | −78.2% |
| 447 | Aligos Therapeutics, Inc.ALGSAligos Therapeutics, Inc. | $25.4M | — | — | +893.0% | −42.7% |
| 448 | BeyondSpring Inc.BYSIBeyondSpring Inc. | $25.1M | — | — | — | −68.2% |
| 449 | Celularity Inc.CELUCelularity Inc. | $24.7M | — | — | −62.8% | −55.0% |
| 450 | Immutep LimitedIMMPImmutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and au… | $24.6M | — | — | +195.3% | −89.9% |
| 451 | NextCure, Inc.NXTCNextCure, Inc. | $24.4M | — | — | — | −45.7% |
| 452 | Tevogen Bio Holdings Inc.TVGNTevogen Bio Holdings Inc. | $23.3M | — | — | — | −76.2% |
| 453 | Filana Therapeutics, Inc.FLNAFilana Therapeutics, Inc. | $21.9M | — | — | — | −62.9% |
| 454 | CervoMed Inc.CRVOCervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurol… | $21.5M | — | — | — | −80.5% |
| 455 | Enlivex Therapeutics Ltd.ENLVEnlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to… | $21.4M | 0.0x | — | — | −99.5% |
| 456 | Atossa Therapeutics, Inc.ATOSAtossa Therapeutics, Inc. | $21.2M | — | — | — | −82.7% |
| 457 | BioStem Technologies, Inc.BSEMBioStem Technologies, Inc. | $21.1M | — | — | −119.6% | −70.8% |
| 458 | Serina Therapeutics, Inc.SERSerina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. | $20.7M | — | — | — | −66.5% |
| 459 | IGC Pharma, Inc.IGCIGC Pharma, Inc. | $20.7M | — | — | −15.4% | −48.1% |
| 460 | Edesa Biotech, Inc.EDSAEdesa Biotech, Inc. | $20.6M | — | — | — | +25.9% |
| 461 | Cocrystal Pharma, Inc.COCPCocrystal Pharma, Inc. | $20M | — | — | — | +3.0% |
| 462 | Seres Therapeutics, Inc.MCRBSeres Therapeutics, Inc. | $19.7M | — | — | — | −85.7% |
| 463 | Pasithea Therapeutics Corp.KTTAPasithea Therapeutics Corp. | $19.3M | — | — | — | −19.9% |
| 464 | Evaxion Biotech A/SEVAXEvaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. | $18.9M | — | — | +135.9% | −52.1% |
| 465 | Jasper Therapeutics, Inc.JSPRJasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem… | $18.7M | — | — | — | −69.3% |
| 466 | Context Therapeutics Inc.CNTXContext Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. | $17.8M | — | — | — | −81.9% |
| 467 | LeonaBio, Inc.LONALeonaBio, Inc. | $17.4M | — | — | — | +10.1% |
| 468 | Akari Therapeutics, PlcAKTXAkari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. | $16.9M | — | — | — | −70.1% |
| 469 | Estrella Immunopharma, Inc.ESLAEstrella Immunopharma, Inc. | $16.3M | — | — | — | −86.4% |
| 470 | Acumen Pharmaceuticals, Inc.ABOSAcumen Pharmaceuticals Inc. | $16.2M | — | — | — | −88.2% |
| 471 | aTyr Pharma, Inc.ATYRaTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of… | $15.6M | — | — | — | −79.4% |
| 472 | Allarity Therapeutics, Inc.ALLRAllarity Therapeutics, Inc. | $15.4M | — | — | — | −13.1% |
| 473 | Kyntra Bio, Inc.KYNBKyntra Bio, Inc. | $15.1M | 0.1x | — | — | −66.1% |
| 474 | Neuphoria Therapeutics Inc.NEUPNeuphoria Therapeutics, Inc. | $15M | — | — | −92.3% | −35.0% |
| 475 | Citius Pharmaceuticals, Inc.CTXRCitius Pharmaceuticals, Inc. | $15M | — | — | — | −56.0% |
| 476 | Marker Therapeutics, Inc.MRKRMarker Therapeutics, Inc. | $14.9M | — | — | −77.1% | +1.4% |
| 477 | Obsidian Therapeutics Inc.OBXA clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyt… | $14.4M | — | — | — | −30.3% |
| 478 | Dyadic International, Inc.DYAIDyadic International, Inc. | $13.6M | — | — | +1.5% | −65.3% |
| 479 | Quantum BioPharma Ltd.QNTMQuantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechn… | $13.5M | — | — | — | −75.5% |
| 480 | Pluri Inc.PLURPluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-de… | $13.3M | — | — | −24.0% | −62.0% |
| 481 | Adial Pharmaceuticals, Inc.ADILAdial Pharmaceuticals, Inc. | $13.3M | — | — | — | −46.8% |
| 482 | Lipocine Inc.LPCNLipocine Inc. | $12.9M | — | — | −62.7% | −40.5% |
| 483 | BioCardia, Inc.BCDABioCardia, Inc. | $12.9M | — | — | — | −33.6% |
| 484 | Passage Bio, Inc.PASGPassage Bio, Inc. | $12.8M | — | — | — | −38.9% |
| 485 | Tvardi Therapeutics, Inc.TVRDTvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapi… | $12.8M | — | — | — | −75.7% |
| 486 | Bolt Biotherapeutics, Inc.BOLTBolt Biotherapeutics, Inc. | $12.6M | — | — | +12.8% | +36.8% |
| 487 | Polyrizon Ltd.PLRZPolyrizon Ltd. | $12.4M | — | — | — | +100.8% |
| 488 | Fractyl Health, Inc.GUTSFractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. | $12.3M | — | — | — | −92.9% |
| 489 | TScan Therapeutics, Inc.TCRXTScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treat… | $11.9M | — | — | +2.2% | −83.8% |
| 490 | Cellectar Biosciences, Inc.CLRBCellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to com… | $11.8M | — | — | — | −63.6% |
| 491 | Kazia Therapeutics Ltd ADRKZIAKazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. | $11.6M | — | — | +250,944.3% | −4.3% |
| 492 | BioVie Inc.BIVIBioVie Inc. | $11.5M | — | — | — | −11.3% |
| 493 | Palatin Technologies, Inc.PTNPalatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of… | $11.2M | — | — | — | −17.7% |
| 494 | Vyome Holdings, Inc.HINDVyome Holdings, Inc. | $11.1M | — | — | −98.0% | −72.1% |
| 495 | CytoMed Therapeutics LimitedGDTCCytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. | $10.2M | — | — | +49.1% | −57.9% |
| 496 | Curanex Pharmaceuticals Inc Common StockCURXCuranex Pharmaceuticals Inc. | $9.7M | — | — | — | −49.3% |
| 497 | Dare Bioscience, Inc.DAREDaré Bioscience, Inc. | $9.6M | — | — | — | −64.7% |
| 498 | MetaVia Inc.MTVAHeadquartered in Cambridge, Massachusetts, MetaVia Inc. | $9.4M | — | — | — | −84.7% |
| 499 | Chemomab Therapeutics Ltd.CMMBChemomab Therapeutics Ltd. | $9.4M | — | — | — | −48.8% |
| 500 | Phio Pharmaceuticals Corp.PHIOPhio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the Un… | $9.3M | — | — | — | −45.9% |
| 501 | Lisata Therapeutics, Inc.LSTALisata Therapeutics, Inc. | $9.3M | — | — | −90.7% | −56.2% |
| 502 | Satellos Bioscience Inc.MSLESatellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australi… | $9.3M | — | — | — | −3.4% |
| 503 | IN8bio, Inc.INABIN8bio, Inc. | $9.1M | — | — | — | −44.2% |
| 504 | Moleculin Biotech, Inc.MBRXMoleculin Biotech, Inc. | $8.9M | — | — | — | −96.2% |
| 505 | AEON Biopharma, Inc.AEONAEON Biopharma, Inc. | $8.8M | — | — | — | −81.9% |
| 506 | BriaCell Therapeutics Corp.BCTXLBriaCell Therapeutics Corp. | $8.5M | — | — | — | −6.2% |
| 507 | BioLineRx Ltd.BLRXBioLineRx Ltd., an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development eff… | $8.5M | — | — | — | −48.6% |
| 508 | Lantern Pharma Inc.LTRNLantern Pharma Inc. | $8.5M | — | — | — | −83.1% |
| 509 | Intensity Therapeutics, Inc.INTSIntensity Therapeutics, Inc. | $8.1M | — | — | — | −75.3% |
| 510 | Actuate Therapeutics IncACTUActuate Therapeutics, Inc. | $7.9M | — | — | — | −94.7% |
| 511 | Theriva Biologics, Inc.TOVXTheriva Biologics Inc. | $7.6M | — | — | — | −39.1% |
| 512 | Tempest Therapeutics, Inc.TPSTTempest Therapeutics Inc. | $7.6M | — | — | — | −96.0% |
| 513 | CollPlant Biotechnologies Ltd.CLGNCollPlant Biotechnologies Ltd. | $7.5M | — | — | −86.8% | −81.8% |
| 514 | Lexaria Bioscience Corp.LEXXLexaria Bioscience Corp. | $7.4M | — | — | −68.5% | −72.2% |
| 515 | Soligenix, Inc.SNGXSoligenix, Inc., a biopharmaceutical firm in its advanced development stages, concentrates on bringing innovative products to market within… | $7.3M | — | — | — | −73.8% |
| 516 | VistaGen Therapeutics, Inc.VTGNVistaGen Therapeutics, Inc. | $7.3M | — | — | +287.3% | −95.9% |
| 517 | Quoin Pharmaceuticals, Ltd.QNRXQuoin Pharmaceuticals, Ltd. | $7.1M | — | — | — | −58.7% |
| 518 | Artelo Biosciences, Inc.ARTLArtelo Biosciences, Inc. | $6.8M | — | — | — | −88.3% |
| 519 | Alzamend Neuro IncALZNAlzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerat… | $6.8M | — | — | — | −44.0% |
| 520 | FibroBiologics, Inc. Common StockFBLGFibroBiologics, Inc. | $6.5M | — | — | — | −85.4% |
| 521 | Aprea Therapeutics, Inc.APREAprea Therapeutics, Inc. | $6.5M | — | — | — | −56.9% |
| 522 | Ensysce Biosciences, Inc.ENSCEnsysce Biosciences, Inc. | $6.4M | — | — | — | −84.1% |
| 523 | Enveric Biosciences, Inc.ENVBEnveric Biosciences, Inc. | $6.4M | — | — | — | −76.4% |
| 524 | Kiora Pharmaceuticals, Inc.KPRXKiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercializa… | $6.4M | — | — | — | −37.9% |
| 525 | Exicure, Inc.XCURExicure, Inc. | $6.2M | — | — | — | −77.7% |
| 526 | AIM ImmunoTech Inc.AIMAIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse… | $6.2M | — | — | −21.5% | −90.1% |
| 527 | Alaunos Therapeutics, Inc.TCRTAlaunos Therapeutics, Inc. | $6M | — | — | −50.0% | −29.3% |
| 528 | Acurx Pharmaceuticals, Inc.ACXPAcurx Pharmaceuticals, Inc. | $5.9M | — | — | — | −78.8% |
| 529 | CNS Pharmaceuticals, Inc.CNSPCNS Pharmaceuticals, Inc. | $5.7M | — | — | — | −43.3% |
| 530 | NuCana plcNCNANuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. | $5.7M | — | — | — | −74.2% |
| 531 | GT Biopharma, Inc.GTBPGT Biopharma, Inc. | $5.6M | — | — | — | −68.1% |
| 532 | Longeveron Inc.LGVNLongeveron Inc. | $5.5M | — | — | −42.7% | −76.5% |
| 533 | Processa Pharmaceuticals, Inc.PCSAProcessa Pharmaceuticals, Inc. | $5.4M | — | — | — | −75.6% |
| 534 | Immuron LimitedIMRNImmuron Limited is a biopharmaceutical company focused on the discovery, development, and global commercialization of polyclonal antibodies,… | $5.4M | — | — | +28.7% | −49.9% |
| 535 | SeaStar Medical Holding CorporationICUSeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat… | $5.3M | — | — | +123.6% | −59.2% |
| 536 | Ainos, Inc.AIMDAinos, Inc. | $5.2M | — | — | −87.7% | −76.1% |
| 537 | Pulmatrix, Inc.PULMPulmatrix, Inc. | $5M | — | — | — | −71.1% |
| 538 | Senti Biosciences, Inc.SNTISenti Biosciences, Inc. | $5M | — | — | — | −91.2% |
| 539 | Cardio Diagnostics Holdings, Inc.CDIOCardio Diagnostics Holdings, Inc. | $4.9M | — | — | −25.9% | −55.6% |
| 540 | Imunon, Inc.IMNNImunon, Inc. | $4.7M | — | — | — | −78.7% |
| 541 | Azitra, Inc.AZTRAzitra, Inc. | $4.4M | — | — | — | −83.2% |
| 542 | Skye Bioscience, Inc.SKYESkye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GP… | $4.4M | — | — | — | −91.9% |
| 543 | Xenetic Biosciences, Inc.XBIOXenetic Biosciences, Inc. | $4.4M | — | — | +33.3% | −31.2% |
| 544 | CalciMedica, Inc.CALCCalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-… | $4.3M | — | — | — | −91.1% |
| 545 | GRI Bio, Inc.GRIGRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target dis… | $4.1M | — | — | — | −96.2% |
| 546 | Apimeds Pharmaceuticals US, IncAPUSApimeds Pharmaceuticals US, Inc. | $4.1M | — | — | — | −89.2% |
| 547 | PharmaCyte Biotech, Inc.PMCBPharmaCyte Biotech, Inc. | $3.9M | — | — | — | −57.2% |
| 548 | Dermata Therapeutics, Inc.DRMADermata Therapeutics, Inc. | $3.8M | — | — | — | −74.1% |
| 549 | Addex Therapeutics LtdADXNAddex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advanceme… | $3.6M | — | — | −48.1% | −66.9% |
| 550 | Cadrenal Therapeutics, Inc. Common StockCVKDCadrenal Therapeutics, Inc. | $3.5M | — | — | — | −92.0% |
| 551 | Liminatus Pharma, Inc. Class A Common StockLIMNLiminatus Pharma, Inc. | $3.4M | — | — | — | −96.0% |
| 552 | Traws Pharma, Inc.TRAWTraws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications de… | $3.4M | — | — | +606.3% | −89.1% |
| 553 | NeuroSense Therapeutics Ltd.NRSNNeuroSense Therapeutics Ltd. | $3.2M | — | — | — | −91.8% |
| 554 | Ernexa Therapeutics Inc.ERNAErnexa Therapeutics Inc. | $3.1M | — | — | — | −95.6% |
| 555 | KALA BIO, Inc.KALAKala Bio, Inc. | $3M | — | — | — | −99.6% |
| 556 | Jupiter Neurosciences, Inc.JUNSJupiter Neurosciences, Inc. | $2.9M | — | — | — | −97.8% |
| 557 | Clearmind Medicine Inc.CMNDClearmind Medicine Inc. | $2.8M | — | — | — | −99.8% |
| 558 | Aptevo Therapeutics Inc.APVOAptevo Therapeutics Inc. | $2.7M | — | — | — | −95.3% |
| 559 | Medicus Pharma Ltd. Common StockMDCXMedicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaki… | $2.7M | — | — | — | −98.5% |
| 560 | Mustang Bio, Inc.MBIOMustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cance… | $2.7M | — | — | — | −68.7% |
| 561 | Onconetix, Inc.ONCOOnconetix, Inc. | $2.5M | — | — | −51.3% | −99.5% |
| 562 | MBody AI Ltd.MBAIMBody AI Ltd. | $2.4M | 0.5x | — | — | −71.5% |
| 563 | VivoSim Labs, Inc.VIVSVivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional… | $2.3M | — | — | −21.1% | −93.5% |
| 564 | Evogene Ltd.EVGNEvogene Ltd., along with its subsidiaries, operates as a computational biology firm. | $2.3M | — | — | −80.4% | −76.6% |
| 565 | Revelation Biosciences, Inc.REVBRevelation Biosciences, Inc. | $2.2M | — | — | — | −86.2% |
| 566 | Can-Fite BioPharma Ltd.CANFCan-Fite BioPharma Ltd., an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic prod… | $2.1M | — | — | −27.7% | −80.7% |
| 567 | BioRestorative Therapies, Inc.BRTXBioRestorative Therapies, Inc. | $2.1M | — | — | −8.5% | −94.6% |
| 568 | 60 Degrees Pharmaceuticals, Inc.SXTP60 Degrees Pharmaceuticals, Inc. | $2.1M | — | — | +68.0% | −88.6% |
| 569 | Co-Diagnostics, Inc.CODXCo-Diagnostics, Inc. | $1.9M | — | — | −28.1% | −97.8% |
| 570 | Propanc Biopharma, Inc.PPCBPropanc Biopharma, Inc. | $1.8M | — | — | — | −99.4% |
| 571 | Calidi Biotherapeutics, Inc.CLDICalidi Biotherapeutics, Inc. | $1.8M | — | — | — | −97.4% |
| 572 | Curis, Inc.CRISCuris, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the… | $1.8M | — | — | −62.2% | −96.9% |
| 573 | XORTX Therapeutics Inc.XRTXXORTX Therapeutics Inc. | $1.7M | — | — | — | −68.7% |
| 574 | Kairos Pharma, Ltd.KAPAKairos Pharma, Ltd. | $1.7M | — | — | — | −92.0% |
| 575 | Creative Medical Technology Holdings, Inc.CELZCreative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatme… | $1.6M | — | — | −50.0% | −79.1% |
| 576 | GeoVax Labs, Inc.GOVXGeoVax Labs, Inc. | $1.6M | — | — | — | −98.8% |
| 577 | Oragenics, Inc.OGENOragenics, Inc. | $1.6M | — | — | — | −68.8% |
| 578 | TransCode Therapeutics, Inc.RNAZTransCode Therapeutics, Inc. | $1.5M | — | — | — | −84.3% |
| 579 | Silo Pharma, Inc.SILOSilo Pharma Inc. | $1.5M | — | — | −25.0% | −82.0% |
| 580 | XTL Biopharmaceuticals Ltd.XTLBXTL Biopharmaceuticals Ltd. | $1.5M | — | — | — | −61.3% |
| 581 | PMGC Holdings Inc.ELABPMGC Holdings Inc. | $1.3M | — | — | — | −100.0% |
| 582 | Karyopharm Therapeutics Inc.KPTIKaryopharm Therapeutics Inc. | $1.2M | — | — | +6.8% | −98.9% |
| 583 | Radiopharm Theranostics LimitedRADXRadiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cuttin… | $1.2M | — | — | — | −78.8% |
| 584 | NewcelX Ltd.NCELNewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeuti… | $1.2M | 8.3x | — | — | −34.4% |
| 585 | Bone Biologics CorporationBBLGBone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanc… | $1.1M | — | — | — | −82.5% |
| 586 | Valion Bio, Inc.VBIOValion Bio, Inc. | $1.1M | — | — | −139.8% | −99.1% |
| 587 | Virax Biolabs Group LimitedVRAXVirax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. | $1.1M | — | — | −87.7% | −93.7% |
| 588 | Genprex, Inc.GNPXGenprex, Inc. | $1M | — | — | — | −98.0% |
| 589 | Jaguar Health, Inc.JAGXJaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal pati… | $939K | — | — | +135.5% | −100.0% |
| 590 | Lunai Bioworks Inc.LNAILunai Bioworks Inc. | $830K | — | — | — | −97.9% |
| 591 | Lakewood-Amedex Biotherapeutics, Inc.LABTLakewood-Amedex Biotherapeutics, Inc. | $676K | — | — | — | −99.3% |
| 592 | Moolec Science S.A.MLECMoolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietar… | $617K | — | — | — | −91.2% |
| 593 | CDT Equity Inc.CDTCDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. | $611K | — | — | — | −100.0% |
| 594 | Decoy Therapeutics Inc.DCOYBased in Cambridge, Massachusetts, Decoy Therapeutics Inc. | $601K | — | — | — | −96.7% |
| 595 | Matinas BioPharma Holdings, Inc.MTNBMatinas BioPharma Holdings, Inc. | $508K | — | — | — | −93.5% |
| 596 | SeaStar Medical Holding CorporationICUCWBased in Denver, Colorado, SeaStar Medical Holding Corporation operates as a medical device company. | $440K | — | — | +123.6% | −61.8% |
| 597 | Tessera Defense and Homeland Security IncHLSQTessera Defense & Homeland Security, Inc. | $362K | — | — | — | −81.8% |
| 598 | HCW Biologics Inc.HCWBHCW Biologics Inc. | $355K | — | — | +707.0% | −94.9% |
| 599 | SciSparc Ltd.SPRCSciSparc Ltd. | $243K | — | — | −68.3% | −98.3% |
| 600 | Biodexa Pharmaceuticals PlcBDRXBiodexa Pharmaceuticals Plc, a biopharmaceutical company in the clinical development stage, is dedicated to advancing a diverse portfolio of… | $231K | — | — | — | −98.8% |
| 601 | Scinai Immunotherapeutics Ltd.SCNIScinai Immunotherapeutics Ltd. | $228K | — | — | +10.9% | −95.8% |
| 602 | Purple Biotech Ltd.PPBTPurple Biotech Ltd., a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer pa… | $181K | — | — | — | −82.3% |
| 603 | Niki BioSolutions, Inc.NIKINiki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. | $129K | — | — | — | −98.8% |
| 604 | Silexion Therapeutics Ltd.SLXNSilexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based canc… | $61K | — | — | — | −99.5% |
| 605 | Psyence Biomedical Ltd.PBMPsyence Biomedical Ltd. | $56K | — | — | — | −80.3% |
| 606 | CDT Equity Inc.CDTTWCDT Equity Inc., established in October 2021 by David Joszef Tapolczay and Freda C. | $8K | — | — | — | −60.6% |
Other industries in Healthcare
Drug Manufacturers - General19Medical - Diagnostics & Research42Medical - Devices124Medical - Healthcare Plans11Medical - Instruments & Supplies47Drug Manufacturers - Specialty & Generic66Medical - Care Facilities52Medical - Distribution10Medical - Pharmaceuticals25Medical - Healthcare Information Services35Medical - Specialties19Medical - Equipment & Services1
Listed mechanically from public data. Not a recommendation to buy or sell any security.